@makis_mediclne: ๐จ DR. WILLIAM MAKIS' UPDATED IVERMECTIN & FENBENDAZOLE CANCER PROTOCOL IS GETTING PEOPLE TALKING Cancer patients aren't saving this chart because it's controversial. They're saving it because they're looking for answers. And according to Dr. William Makis, one of the biggest mistakes people make is assuming every cancer case should follow the same protocol. That's why his updated protocol doesn't use one dose. It uses FOUR. ๐ The goal? To adjust dosing based on: ๐ Cancer aggressiveness ๐ Tumor burden ๐ Metastatic spread ๐ Overall prognosis ๐ Individual response โโโโโโโโโโโโโโ ๐ข LOW DOSE IVERMECTIN โค 0.5 mg/kg 3x per week FENBENDAZOLE 222 mg/day 3 days on, 4 days off Often discussed for: โข Remission support โข Prevention โข Strong family history โข Higher risk individuals โโโโโโโโโโโโโโ ๐ก MEDIUM DOSE IVERMECTIN 1.0 mg/kg daily FENBENDAZOLE 222 mg/day 6 days per week Often discussed for: โข Most active cancers โข Common starting approach โโโโโโโโโโโโโโ ๐ต HIGH DOSE IVERMECTIN 2.0 mg/kg daily FENBENDAZOLE 444 mg/day 6 days per week Often discussed for: โข Aggressive cancers โข Brain cancers โข Leukemia โข Pancreatic cancer โโโโโโโโโโโโโโ ๐ด VERY HIGH DOSE IVERMECTIN โฅ 2.5 mg/kg daily FENBENDAZOLE 888 to 1000 mg/day 6 days per week Often discussed for: โข Extensive metastatic disease โข Poor prognosis cases โโโโโโโโโโโโโโ ๐ก Additional Protocol Notes โ Many patients combine Ivermectin and Fenbendazole โ Some alternate Fenbendazole with Mebendazole โ Fenbendazole is commonly taken with fatty meals โ Liver support is frequently discussed โ Long term use and monitoring are commonly emphasized โโโโโโโโโโโโโโ ๐ฌ What Makes This Protocol Different? It's not the dosages. It's the idea behind them. Dr. Makis argues that cancer isn't one disease. A patient in remission is different from a patient with widespread metastatic disease. A slow growing cancer is different from an aggressive one. And because of that, many people believe a one size fits all approach may not always make sense. That's one reason why interest in repurposed medicines continues to grow. ๐ฌ Researchers have spent years investigating how compounds like Ivermectin and Fenbendazole may interact with: โข Cancer metabolism โข Cancer stem cells โข Mitochondrial function โข Tumor signaling pathways โข Treatment resistance mechanisms โข Cellular energy production Whether these findings ultimately change clinical practice remains to be seen. But one thing is undeniable: More cancer patients, caregivers, and researchers are discussing repurposed medicines today than ever before. And that's exactly why charts like this keep getting shared. ๐ Save this chart now. Six months from now, you'll wish you knew where to find it. ๐ Repost it so more people researching cancer protocols can see it. ๐ฌ Have you been following Dr. William Makis' work on Ivermectin and Fenbendazole? ๐ Many people researching Ivermectin and Fenbendazole have discovered @RxMeds_store. #Ivermectin #Fenbendazole #CancerResearch #CancerProtocol #RepurposedDrugs
